Skip to content

Analysis of the efficacy of rTMS neuromodulation of early idiopathic facial nerve palsy

Analysis of the efficacy of rTMS neuromodulation of early idiopathic facial nerve palsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072289
Enrollment
Unknown
Registered
2023-06-08
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell's palsy

Interventions

Stimulation group:Conventional treatment+ Repetitive transcranial magnetic stimulation
Control group:Conventional treatment of Bell's palsy

Sponsors

The Fifth Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients were diagnosed according to the guidelines published by the American Academy of Otolaryngology-Head and Neck Surgery Foundation ( AAO-HNSF ) in 2013, and the inclusion criteria were: ?meeting the above diagnostic criteria; ?age 15-80 years old, regardless of gender; ?first-onset, unilateral facial palsy with a duration of less than 10 days and without any treatment; ?FNGS score =10; ?receiving repeated transcranial magnetic therapy and who signed the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria: ?Patients with confirmed central facial palsy; ?Patients with other causes of peripheral facial palsy (e.g., surgical injury, posterior cranial fossa tumor, Lyme disease, Guillain-Barré syndrome, etc.); ?Exclusion of severe cardiac, hepatic, renal, and metabolic diseases, oncological diseases, psychiatric diseases, and pregnant and lactating female patients. ? Contraindications to transcranial magnetic stimulation therapy such as intracranial metallic foreign body, epilepsy history, pacemaker implantation, etc. (6) Patients with impaired consciousness and inability to cooperate with treatment.

Design outcomes

Primary

MeasureTime frame
Facial Nerve Grading System2.0;

Countries

China

Contacts

Public ContactGuoYongkun

The Fifth Affiliated Hospital of Zhengzhou University

yongkunhope@126.com+86 159 3623 1876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026